Competitive analysis of “ROSUVASTATIN” & “TELMISARTAN” ” for Cipla pharmaceutical in the pharmaceutical industry conducted at Coimbatore‚ Tamilnadu Submitted in partial fulfillment of the award of the degree of Master of Business Administration Mahatma Gandhi University Submitted By MANISH.K.B Reg.No 60810 Under the Guidance of ANU ANNA ANTHONY [pic] Sree Narayana Guru Institute of Science & Technology North Paravur‚ Ernakulam 2005-2007 Date: 30/08/2006
Premium Pharmacology Pharmaceutical industry Drug discovery
Worksheet for Computron: Competitive Bidding Assignment: Analyze the case. Summarize your analysis of alternative bidding strategies in the following table. (Identify the key criteria. Evaluate the alternative bidding strategies on each criterion.) Draw an appropriate conclusion. Criteria | Alternatives | | I. Submit bid at list price | II. Cut Price (16 %) | III. Do not Bid | High DependabilityReasonable PriceLow Emphasis on FlexibilityPinpoint Accuracy Not Required | Advantages1. Maintain
Premium Term Competition Time
Main issue: European Sales Division of Computron had to decide what price to submit for its Computron 1000X digital computer for the bid of a purchase contract from Konig & Cie.‚ AG. * Four other computer manufacturers‚ including RMAG‚ EDAG and Digitex‚ would bid for the contract. The competitors’ prices will most likely be around the $872‚000 proposed by RMAG. * Computron used cost based pricing (firm’s standard pricing policy): The European Price= U.S. cost + 33.33% x Cost (Markup)
Premium Pricing Price Competition
Researcher’s View: Sourcing accurate and reliable quantitative data on Tanzania’s pharmaceutical market remains challenging due to substandard audits‚ porous sales channels‚ a high prevalence of counterfeits‚ questionable national statistics‚ dispensing without prescriptions‚ sizeable ‘grey markets’ and the widespread use of traditional remedies. Researcher takes into account the import dependence of countries for medicines and assumes that economic growth as well as the resulting increase in the
Premium Economics Medicine Pharmaceutical drug
University of Pennsylvania ScholarlyCommons Master of Science in Organizational Dynamics Theses 5-4-2010 Organizational Dynamics Programs Problems Facing the Pharmaceutical Industry and Approaches to Ensure Long Term Viability Donald A. Baines University of Pennsylvania‚ djtz00@aol.com Submitted to the Program of Organizational Dynamics in the Graduate division of the School of Arts and Sciences in Partial Fulfillment of the Requirements for the Degree of Master of Science in the Organizational
Premium Pharmaceutical industry Generic drug
In-Depth Integrative Case 1.2 Pharmaceutical Companies‚ Intellectual Property‚ and the Global AIDS Epidemic In-Depth Case 1.2 1. Do pharmaceutical companies have the responsibility to distribute drugs for a low cost in developing countries? What are the main arguments for and against such an approach? What are the advantages and the disadvantages of giving drugs for free versus offering them at low no-profit prices? The Aids epidemic is responsible for taking millions of lives worldwide
Premium Pharmacology Medicine Pharmaceutical drug
Takeda Pharmaceutical Company Limited is the largest pharmaceutical company in Asia. This company has been making headlines due to its benevolence and effective charity. Takeda identifies CSR-related material issues through discussion with the communities formed by global enterprises‚ international NGOs and institutions involved in healthcare worldwide‚ including other global pharmaceutical companies‚ while referring to internal management strategy and management resources. The Takeda-Plan Healthcare
Premium Takeda Pharmaceutical Company Takeda Pharmaceutical Company
strategy? Anticipating sustainability for generic pharmaceutical industry Journal of Medical Marketing 2014‚ Vol. 14(2–3) 81–90 ! The Author(s) 2014 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav DOI: 10.1177/1745790414556563 mmj.sagepub.com Fereshteh Barei1 and Claude Le Pen2 Abstract The repercussions of product innovation crisis in big pharma drive the generic pharmaceutical industry to lower its dependence on original pharmaceutical industry. Moreover‚ an important change is happening
Premium Drug development Pharmaceutical industry Drug discovery
Finance - Case Study Situation - Computron (expansion Program) A. Sales have been below forecasted numbers B. cost have been higher than projected C. They suffered a profit loss instead of a gain D. Management‚ investors and directors are concerned. E. It’d tsking s long time for dvertisement programs to get across all business units‚ including sales and operations Problem - Computron is faced with alot of problems that have impacted their business and caused them to suffer financially
Premium Financial ratios Financial ratio
Discuss issues associated with pharmaceutical transnational corporations regarding research‚ production and distribution of drugs. (15 marks) An example of an issue with pharmaceutical drug corporations is the ethics associated with researching the drugs. For example‚ Pfizer caused an international scandal when they illegally tested a drug to cure meningitis in Nigeria. 11 children died due to not enough research into the effects of the drug on children. This is an ethical issue‚ as if Pfizer
Premium Pharmacology Pharmaceutical drug Medicine